Objective:

To discuss the potential of laminar fMRI in bridging the gap between nano-scale mechanisms of epilepsy and macro-scale clinical observations, emphasizing its significance in improving treatment outcomes.

Key Findings:

• Drug-resistant epilepsy affects 25%-30% of patients, highlighting limitations in current treatments.
• Antiseizure medications primarily target nano-scale structures but are assessed at the macro-scale, creating a disconnect in understanding.
• Microcircuits, particularly deep cortical layers, play a critical role in seizure generation and propagation.
• Laminar fMRI can provide insights into layer-specific mechanisms of seizure activity, potentially revealing new therapeutic targets.

Interpretation:

The findings suggest that laminar fMRI could enhance understanding of epilepsy by linking micro-scale dysfunctions to macro-scale seizure activity, potentially improving treatment strategies through targeted interventions.

Limitations:

• The review is based on existing literature and may not include all recent advancements in the field, which could affect the comprehensiveness of the findings.
• The effectiveness of laminar fMRI in clinical settings remains to be fully validated, indicating a need for further research.

Conclusion:

Laminar fMRI holds promise for refining surgical targeting in focal epilepsies and elucidating the mechanistic effects of antiseizure medications, potentially leading to improved epilepsy treatments and guiding future research directions.